BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33321824)

  • 21. Comparison of breath sampling methods: a post hoc analysis from observational cohort studies.
    Berna AZ; Schaber CL; Bollinger LB; Mwale M; Mlotha-Mitole R; Trehan I; Odom John AR
    Analyst; 2019 Mar; 144(6):2026-2033. PubMed ID: 30702091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of volatile organic compounds from lung cancer patients and healthy controls-challenges and limitations of an observational study.
    Schallschmidt K; Becker R; Jung C; Bremser W; Walles T; Neudecker J; Leschber G; Frese S; Nehls I
    J Breath Res; 2016 Oct; 10(4):046007. PubMed ID: 27732569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variation of volatile organic compound levels within ambient room air and its impact upon the standardisation of breath sampling.
    Hewitt MJ; Belluomo I; Zuffa S; Boshier PR; Myridakis A
    Sci Rep; 2022 Sep; 12(1):15887. PubMed ID: 36151300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breath volatile organic compounds of lung transplant recipients with and without chronic lung allograft dysfunction.
    Küppers L; Holz O; Schuchardt S; Gottlieb J; Fuge J; Greer M; Hohlfeld JM
    J Breath Res; 2018 Jun; 12(3):036023. PubMed ID: 29771243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human breath analysis: methods for sample collection and reduction of localized background effects.
    Martin AN; Farquar GR; Jones AD; Frank M
    Anal Bioanal Chem; 2010 Jan; 396(2):739-50. PubMed ID: 19844696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of breath volatile organic compounds in acute cardiorespiratory breathlessness: a protocol describing a prospective real-world observational study.
    Ibrahim W; Wilde M; Cordell R; Salman D; Ruszkiewicz D; Bryant L; Richardson M; Free RC; Zhao B; Yousuf A; White C; Russell R; Jones S; Patel B; Awal A; Phillips R; Fowkes G; McNally T; Foxon C; Bhatt H; Peltrini R; Singapuri A; Hargadon B; Suzuki T; Ng LL; Gaillard E; Beardsmore C; Ryanna K; Pandya H; Coates T; Monks PS; Greening N; Brightling CE; Thomas P; Siddiqui S
    BMJ Open; 2019 Mar; 9(3):e025486. PubMed ID: 30852546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Miniaturization of breath sampling with silicon chip: application to volatile tobacco markers tracking.
    Chappuis TH; Pham Ho BA; Ceillier M; Ricoul F; Alessio M; Beche JF; Corne C; Besson G; Vial J; Thiébaut D; Bourlon B
    J Breath Res; 2018 Sep; 12(4):046011. PubMed ID: 30008462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alveolar air volatile organic compound extractor for clinical breath sampling.
    de Silva G; Beyette FR
    Annu Int Conf IEEE Eng Med Biol Soc; 2014; 2014():5369-72. PubMed ID: 25571207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An adaptive breath sampler for use with human subjects with an impaired respiratory function.
    Basanta M; Koimtzis T; Singh D; Wilson I; Thomas CL
    Analyst; 2007 Feb; 132(2):153-63. PubMed ID: 17260076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral or nasal breathing? Real-time effects of switching sampling route onto exhaled VOC concentrations.
    Sukul P; Oertel P; Kamysek S; Trefz P
    J Breath Res; 2017 Mar; 11(2):027101. PubMed ID: 28244881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Some insights into analytical bias involved in the application of grab sampling for volatile organic compounds: a case study against used Tedlar bags.
    Ghosh S; Kim KH; Sohn JR
    ScientificWorldJournal; 2011; 11():2160-77. PubMed ID: 22235175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative analyses of volatile organic compounds (VOCs) from patients, tumors and transformed cell lines for the validation of lung cancer-derived breath markers.
    Filipiak W; Filipiak A; Sponring A; Schmid T; Zelger B; Ager C; Klodzinska E; Denz H; Pizzini A; Lucciarini P; Jamnig H; Troppmair J; Amann A
    J Breath Res; 2014 Jun; 8(2):027111. PubMed ID: 24862102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Applied upper-airway resistance instantly affects breath components: a unique insight into pulmonary medicine.
    Sukul P; Schubert JK; Kamysek S; Trefz P; Miekisch W
    J Breath Res; 2017 Nov; 11(4):047108. PubMed ID: 28925377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of volatile organic compounds in exhaled breath by gas chromatography-mass spectrometry combined with chemometric analysis.
    Dallinga JW; Smolinska A; van Schooten FJ
    Methods Mol Biol; 2014; 1198():251-63. PubMed ID: 25270934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of volatile organic compounds in exhaled breath of heart failure patients by needle trap micro-extraction coupled with gas chromatography-tandem mass spectrometry.
    Biagini D; Lomonaco T; Ghimenti S; Bellagambi FG; Onor M; Scali MC; Barletta V; Marzilli M; Salvo P; Trivella MG; Fuoco R; Di Francesco F
    J Breath Res; 2017 Nov; 11(4):047110. PubMed ID: 29052557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultrafast gas chromatography coupled to electronic nose to identify volatile biomarkers in exhaled breath from chronic obstructive pulmonary disease patients: A pilot study.
    Rodríguez-Aguilar M; Ramírez-García S; Ilizaliturri-Hernández C; Gómez-Gómez A; Van-Brussel E; Díaz-Barriga F; Medellín-Garibay S; Flores-Ramírez R
    Biomed Chromatogr; 2019 Dec; 33(12):e4684. PubMed ID: 31423612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emissions and uptake of volatiles by sampling components in breath analysis.
    Pham YL; Holz O; Beauchamp J
    J Breath Res; 2023 May; 17(3):. PubMed ID: 37074671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A rapid method for breath analysis in cystic fibrosis patients.
    Kramer R; Sauer-Heilborn A; Welte T; Guzman CA; Höfle MG; Abraham WR
    Eur J Clin Microbiol Infect Dis; 2015 Apr; 34(4):745-51. PubMed ID: 25431363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methodology validation, intra-subject reproducibility and stability of exhaled volatile organic compounds.
    Basanta M; Ibrahim B; Douce D; Morris M; Woodcock A; Fowler SJ
    J Breath Res; 2012 Jun; 6(2):026002. PubMed ID: 22549110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease.
    Pizzini A; Filipiak W; Wille J; Ager C; Wiesenhofer H; Kubinec R; Blaško J; Tschurtschenthaler C; Mayhew CA; Weiss G; Bellmann-Weiler R
    J Breath Res; 2018 Mar; 12(3):036002. PubMed ID: 29295966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.